Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Simon P. Newman
STX140, but Not Paclitaxel, Inhibits Mammary Tumour Initiation and Progression in C3(1)/Sv40 T/T-Antigen Transgenic Mice
PLoS ONE
Multidisciplinary
Synthesis, Anti-Tubulin and Antiproliferative SAR of Steroidomimetic Dihydroisoquinolinones
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Related publications
Mullerian Inhibiting Substance Suppresses Tumor Growth in the C3(1)T Antigen Transgenic Mouse Mammary Carcinoma Model
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The SV40 Small T-Antigen Prevents Mammary Gland Differentiation and Induces Breast Cancer Formation in Transgenic Mice; Truncated Large T-Antigen Molecules Harboring the Intact P53 and pRb Binding Region Do Not Have This Effect
Oncogene
Cancer Research
Genetics
Molecular Biology
Efficient Eradication of Subcutaneous but Not of Autochthonous Gastric Tumors by Adoptive T Cell Transfer in an SV40 T Antigen Mouse Model
Journal of Immunology
Allergy
Immunology
Immortalization of Neuro-Endocrine Cells From Adrenal Tumors Arising in SV40 T-Transgenic Mice
Oncogene
Cancer Research
Genetics
Molecular Biology
TAF-like Function of SV40 Large T Antigen.
Genes and Development
Genetics
Developmental Biology
SV40 T-Antigen Is Required for Maintenance of Immortal Growth in SV40-transformed Human Fibroblasts.
Cell Structure and Function
Medicine
Cell Biology
Molecular Biology
Physiology
Simian Virus 40 (SV40) DNA Replication: SV40 Large T Antigen Unwinds DNA Containing the SV40 Origin of Replication.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Expansion of Natural Killer Cells but Not T Cells in Human Interleukin 2/Interleukin 2 Receptor (Tac) Transgenic Mice
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Selective Antigen-Specific CD4+T-cell, but Not CD8+T- Or B-Cell, Tolerance Corrupts Cancer Immunotherapy
European Journal of Immunology
Allergy
Immunology
